Lonza, Bar Harbor Biotech Expand Pact

Feb 04, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bar Harbor BioTechnology and Lonza have expanded their distribution partnership to include new qPCR array tools, Lonza said today.

The companies first struck an exclusive distribution agreement in 2008 that covered the StellARray Gene Expression System, which is used by researchers to accurately detect small changes in gene expression or to measure copy number variations. Lonza will now distribute the system along with the Global Pattern Recognition 2.0 software, Custom Plate Designer, and XenoQ products, which were launched in January.

Lonza's Research Solutions Director of Product Marketing Dietmar Pein said that expression profiling by qPCR arrays, particularly when used in combination with new solutions that address normalization and customization challenges, will become more important in life sciences research.

Filed under

Microarrays & Multiplexing

Gene Expression & RNA Sequencing

PCR

distribution agreement

gene expression

Bar Harbor BioTechnology

Lonza

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.